elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q27008080-A3C05574-57D2-4321-BD3C-7FD101E0C445
Q27008080-A3C05574-57D2-4321-BD3C-7FD101E0C445
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27008080-A3C05574-57D2-4321-BD3C-7FD101E0C445
The impact of primary prophylaxis with granulocyte colony-stimulating factors on febrile neutropenia during chemotherapy: a systematic review and meta-analysis of randomized controlled trials
P2860
Q27008080-A3C05574-57D2-4321-BD3C-7FD101E0C445
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27008080-A3C05574-57D2-4321-BD3C-7FD101E0C445
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
22586eafeb2ac796197df3a8701075111a90cc0b
P2860
XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy.